Description
Product Specifications
| Attribute | Details |
|---|---|
| Product Name | Dapoxetine Hydrochloride Tablets (Bongo® / Hongqi Pharmaceutical) |
| Generic Name | Dapoxetine Hydrochloride (C??H??NO·HCl) |
| CAS Number | 119356-77-3 |
| Molecular Formula | C-H-NO·HCl ©C-H-NO·HCl |
| Molecular Weight | ~305.4g/mol |
| Dosage Form | Film coated oral tablet |
| Strength | 30mg per tablet |
| Pack Size | 4 tablets × 2 blisters |
| Approval No. | China NMPA H20213748 |
| Product Code | 86910323000123 |
| Manufacturer | Shenyang Hongqi Pharmaceutical Co., Ltd. |
| Barcode | 6975167815429 |
| Storage Conditions | Store at 15–25°C; protect from moisture and light |
| Intended Use | Laboratory research only |
Mechanism of Action
Dapoxetine is a short-acting SSRI that inhibits serotonin reuptake in the central nervous system, enhancing serotonin activity at the synapse. This action prolongs ejaculatory latency through modulation of sensory-spinal-brain circuits (e.g., 5HTA, 5HTB, 5HTC receptors).
Research Applications & Pharmacology
Premature Ejaculation (PE) Models: Significantly increases intravaginal ejaculatory latency time (IELT) when administered on-demand (30mg, sometimes 60mg) .
Mechanistic CNS Studies: Helps explore serotonin signaling and ejaculatory control pathways .
Pharmacokinetics: Rapid absorption, short initial half-life (1–2h), terminal half-life (~15–19h), mainly metabolized via CYP2D6 and CYP3A4, highly protein-bound (>99%) .
Safety Profile & Handling
Common Adverse Events: Nausea, headache, dizziness, diarrhea, insomnia .
Serious Risks: Rare syncope observed shortly after dosing; caution advised in cardiovascular research.
Handling: Store properly, use PPE, and discard expired products per lab protocol.
Contraindications: Avoid in hepatic impairment models or when co-administered with strong CYP3A4 inhibitors or serotonergic drugs


Reviews
There are no reviews yet.